Featured

Agios' PYRUKYND® (mitapivat) Approved for Thalassemia in Saudi Arabia

Agios Pharmaceuticals announced that the Saudi Food and Drug Authority (SFDA) has approved PYRUKYND® (mitapivat) for treating adult patients with non-...

Home/KnolSights/Regulatory Approvals/Agios' PYRUKYND® (mitapivat) Approved for Thalassemia in Saudi Arabia